Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

St. Louis, Missouri 63110


Purpose:

RATIONALE: Imaging procedures, such as carbon-11 acetate positron emission tomography (PET) and fludeoxyglucose F 18 PET, may improve the ability to detect hepatocellular carcinoma (liver cancer) and allow doctors to plan the most effective treatment. PURPOSE: This clinical trial is studying how well carbon-11 acetate PET and fludeoxyglucose F 18 PET work in detecting cancer in patients with liver cancer.


Criteria:

INCLUSION: - Biopsy-proved HCC (stage I and II by conventional staging) or one or more of the following in a patient with clinically documented cirrhosis: - AFP > 200 mg/dL; - A contrast-enhancing tumor mass (>1 cm) by CT or MRI; or - A tumor mass confirmed by arteriography. - Patient must provide written informed consent and have completed conventional imaging and staging before initiation of PET imaging. EXCLUSION: - Pediatric patients under the age of 18 will be excluded from consideration from this study. - Patients with a known prior malignancy (with the exception of basal cell carcinoma of the skin and carcinoma in situ of the cervix) within 5 years will be excluded from entry into the study. However, patients with a prior HCC thought to have a new primary or recurrent HCC are eligible. - Pregnant and breastfeeding patients. - Patients with poorly controlled diabetes mellitus (fasting blood glucose level > 200 mg/dL)


NCT ID:

NCT00081094


Primary Contact:

Principal Investigator
William C. Chapman, M.D.
Washington University School of Medicine


Backup Contact:

N/A


Location Contact:

St. Louis, Missouri 63110
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.